Oneview signs long-term contract with a second Victorian hospital
2 minute read
Oneview Healthcare Plc (ASX:ONE) has signed a new 5-year contract with Northern Health in Melbourne’s fast-growing northern corridor, making it the company’s first Cloud Start customer in Australia.
Northern Health is a provider of public healthcare serving Melbourne’s northern region with five major public healthcare facilities.
Oneview’s Cloud Start product will be deployed to 126 beds in the recently completed $162.3 million Stage 2 Inpatient Unit Expansion Project which became operational on 3 May 2021.
This development is extremely important as it is Oneview’s first cloud win with the public sector in Australia (ONE has 3 hospitals live with NSW Health: Westmead Children’s, Randwick Children’s and Central Acute Services Building), as well as being the group’s first win of any kind with VicHealth.
It is also a positive indicator of demand for the group’s technology and services as it demonstrates that patient experience is a strategic priority for both the public and private sectors.
Cloud Start has tick of approval from Samsung
Oneview’s products include Cloud Start and Cloud Enterprise with the former not requiring integration into the Electronic Health Record, making it easier and faster to deploy.
Importantly, this is the product Samsung is selling in Oneview’s bundled SKU (Stock Keeping Units) in the US.
Hospitals can increase their patient satisfaction scores through technology solutions built by Samsung and its partners.
Samsung is now providing single SKU-bundled solutions for patient engagement that include a secure mobile device and partner software applications.
These bundles enable hospitals and healthcare providers to improve patient usability and functionality while reducing the need for multiple generic devices.
In addition, hospitals can own a fully integrated SKU solution that may be easily deployed within the hospital system.
The system will go live in July and with relatively quick revenue recognition it will be one of the key value drivers of the Cloud product.
Highlighting the importance of this development and the advantages offered by Cloud CXP, Eleni Tzaros, ANZ Sales Director for Oneview said, “We are delighted to welcome Northern Health to our global health service partnerships.
"The Cloud CXP offering has provided Northern Health with the opportunity to catalyse their innovation strategy with the solution due to go live next month.
"This speaks to the importance of Cloud offerings for agility, speed to market and value-based outcomes.”
For more information read: ONE signs ANOTHER deal - the second in 8 days
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.